Chest Compressions to the Left of the Sternum are Associated with Higher Systolic Blood Pressure than to the Lower Sternum
Abstract Body: Introduction/Background Despite over 60 years of cardiopulmonary resuscitation (CPR), there is a paucity of evidence assessing the optimal location to perform chest compressions during cardiac arrest. Some recent imaging studies with transesophageal echocardiography (TEE) and computed tomography (CT) show that the left ventricular outflow tract (LVOT) is often the site of maximum compression with CPR, if using the AHA recommended site of the lower half of the sternum.
Research Questions/Hypothesis We hypothesize that chest compressions performed to the left of the sternum, where the left ventricle is more likely to be located, will be associated with higher systolic blood pressure (SBP) than those performed at the AHA-recommended lower half of the sternum.
Goals/Aims Our primary aim was to compare the highest SBP, measured on a femoral arterial line, during a chest compression (CC) interval at the AHA recommended location (Zone 1, Figure) versus those performed to the left of the sternum (Zone 2, 3, or 4, Figure). Secondarily, we compared the highest end-tidal CO2 (ETCO2) for chest compression intervals performed at Zone 1 vs. Zone 2, 3, or 4.
Methods/Approach We conducted a retrospective cohort study of video-recorded, adult, cardiac arrest resuscitations with changes in chest compression location in a quaternary care Emergency Department (ED) from 3/9/2021 to 2/20/2024. We excluded chest compressions at Zone 5 or 6. Wilcoxon rank sum tests were used to assess differences in SBP and ETCO2 among chest compressions performed at Zone 1 vs. Zones 2, 3, or 4.
Results/Data 24 patients had SBP or ETCO2 recordings, 11 patients with SBP recordings, 18 patients with ETCO2 recordings, and 5 patients with both. For SBP, there were 28 CC intervals in Zone 1 and 32 CC intervals in Zone 2 or 4. The median SBP for Zone 1 was 67 mmHg (IQR 52.25-86.75 mmHg) vs. 103 mmHg (IQR 79-125 mmHg) for Zone 2 or 4 (p<0.001). For ETCO2, there were 44 CC intervals for Zone 1 and 32 for Zone 2, 3, or 4. The median ETCO2 in Zone 1 was 16 mmHg (IQR 12.75-23.75 mmHg) vs. 17.5 mmHg (IQR 13-31.25 mmHg) in Zone 2, 3, or 4 (p=0.517).
Conclusions Chest compressions to the left of the sternum are associated with higher SBP than compressions at the AHA recommended lower half of the sternum. ETCO2 was similar regardless of chest compression location.
Frank, Kevin
( Northwell Health
, Manhasset
, New York
, United States
)
Cohen, Allison
( Northwell Health
, Manhasset
, New York
, United States
)
Haddad, Ghania
( Northwell Health
, Manhasset
, New York
, United States
)
Berruti, Alaina
( Zucker School of Medicine at Hofstra University
, Hempstead
, New York
, United States
)
Li, Timmy
( Northwell Health
, Manhasset
, New York
, United States
)
Young, Elizabeth
( Northwell Health
, Manhasset
, New York
, United States
)
Becker, Lance
( Northwell Health
, Manhasset
, New York
, United States
)
Jafari, Daniel
( Northwell Health
, Manhasset
, New York
, United States
)
Rolston, Daniel
( Northwell Health
, Manhasset
, New York
, United States
)
Author Disclosures:
Kevin Frank:DO NOT have relevant financial relationships
| allison cohen:DO NOT have relevant financial relationships
| Ghania Haddad:DO NOT have relevant financial relationships
| Alaina Berruti:DO NOT have relevant financial relationships
| Timmy Li:DO NOT have relevant financial relationships
| Elizabeth Young:DO NOT have relevant financial relationships
| Lance Becker:DO have relevant financial relationships
;
Advisor:Philips:Active (exists now)
; Research Funding (PI or named investigator):United Therapeutics:Active (exists now)
; Research Funding (PI or named investigator):NIH:Active (exists now)
; Research Funding (PI or named investigator):HP:Past (completed)
; Research Funding (PI or named investigator):Nihon Kohden:Active (exists now)
; Research Funding (PI or named investigator):Philips:Active (exists now)
; Advisor:HP:Active (exists now)
; Advisor:Nihon Kohden:Active (exists now)
| Daniel Jafari:DO have relevant financial relationships
;
Research Funding (PI or named investigator):Zoll foundation :Past (completed)
; Research Funding (PI or named investigator):Theravance Biopharma :Past (completed)
| Daniel Rolston:No Answer